Monoclonal Antibody for Autoimmune Diseases Targeting BSSL
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
56
NCT05576012
First in Human Study of a Monoclonal Antibody (SOL-116) Targeting BSSL (Bile Salt-Stimulated Lipase), Single and Multiple Dose Parts
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 13, 2022
Completion: Nov 28, 2024
Loading map...